Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Lawrence

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|February 26, 2004
Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous systemManuel Yepes, Daniel A Lawrence
Experimental Biology and Medicine (Maywood, N.J.)|November 27, 2004
New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous systemManuel Yepes, Daniel A Lawrence
Science'S STKE : Signal Transduction Knowledge Environment|July 3, 2003
Old dogs and new tricks: proteases, inhibitors, and cell migrationSteingrimur Stefansson, Daniel A Lawrence
Nature Medicine|November 9, 2011
Tissue factor and obesity, a two-way streetNan Zhang, Daniel A Lawrence
Trends in Cardiovascular Medicine|July 21, 2004
Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system?Manuel Yepes, Daniel A Lawrence
Methods (San Diego, Calif.)|December 31, 2003
Serpin mutagenesisToni M Antalis, Daniel A Lawrence
Current Drug Targets|September 28, 2007
Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agentJacqueline M Cale, Daniel A Lawrence
Eneuro|August 10, 2018
Characterization of Tissue Plasminogen Activator Expression and Trafficking in the Adult Murine BrainTamara K Stevenson, Daniel A Lawrence
Methods in Enzymology|November 15, 2011
Development of inhibitors of plasminogen activator inhibitor-1Shih-Hon Li, Daniel A Lawrence
Blood|August 11, 2012
The functional dissonance of plateletsEnming Joseph Su, Daniel A Lawrence
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|February 26, 2004
Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous systemManuel Yepes, Daniel A Lawrence
Experimental Biology and Medicine (Maywood, N.J.)|November 27, 2004
New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous systemManuel Yepes, Daniel A Lawrence
Science'S STKE : Signal Transduction Knowledge Environment|July 3, 2003
Old dogs and new tricks: proteases, inhibitors, and cell migrationSteingrimur Stefansson, Daniel A Lawrence
Nature Medicine|November 9, 2011
Tissue factor and obesity, a two-way streetNan Zhang, Daniel A Lawrence
Trends in Cardiovascular Medicine|July 21, 2004
Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system?Manuel Yepes, Daniel A Lawrence
Methods (San Diego, Calif.)|December 31, 2003
Serpin mutagenesisToni M Antalis, Daniel A Lawrence
Current Drug Targets|September 28, 2007
Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agentJacqueline M Cale, Daniel A Lawrence
Eneuro|August 10, 2018
Characterization of Tissue Plasminogen Activator Expression and Trafficking in the Adult Murine BrainTamara K Stevenson, Daniel A Lawrence
Methods in Enzymology|November 15, 2011
Development of inhibitors of plasminogen activator inhibitor-1Shih-Hon Li, Daniel A Lawrence
Blood|August 11, 2012
The functional dissonance of plateletsEnming Joseph Su, Daniel A Lawrence
Pageof 14